Ex vivo assays to evaluate the role of protein kinase C in tumor cells of patients with breast cancer

Anticancer Research

Volumn 20, Issue 6 D, 2000, Pages 5073-5076

  Schondorf T ^a   Becker, M ^a   Kolhagen, H ^a   Kurbacher, C M ^a   Gohring U J ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Breast cancer; Chemosensitivity; PKC; Proteinkinase C; Signal transduction

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ISOENZYME; MITOXANTRONE; NAVELBINE; PACLITAXEL; PROTEIN KINASE C; TAMOXIFEN;

BREAST CANCER; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MIXTURE; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; ISOENZYMES; PROTEIN KINASE C; TUMOR CELLS, CULTURED;

EID: 0034451225     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Molecular insights into cancer invasion: Strategies for prevention and intervention
2. Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue
3. Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue
4. ras -generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2
5. Selective modulation of protein kinase A and protein kinase C activities in epidermal growth factor (EGF)-stimulated MCF-7 breast cancer cells
6. Possible roles of bFGF and PKC in the evolution of metastases in malignant melanoma and gastric adenocarcinoma
7. Protein kinase C ζ isoform is critical for mitogenic signal transduction
8. PKC ζ is a molecular switch in signal transduction of TNFa, bifunctionally regulated by ceramide and arachidonic acid
9. P-glycoproteins and multidrug resistance
10. MDR1 gene expression in solid tumours
11. Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/Adr breast carcinoma cells
12. Differential expression and activity of phosphatases and protein kinases in adriamycin sensitive and resistant human breast cancer MCF-7 cells
13. Interaction of P-glycoprotein with protein kinase C in human multidrug resistant carcinoma cells
14. Signaling and drug sensitivity
15. Targeting signal transduction for disease therapy
16. Multimodality therapy: Radiation and continuous concomitant cis-platinum and PKC inhibition in a cervical carcinoma model
17. Directed antisense therapy confirms the role of protein kinase C-α in the tumorigenicity of pancreatic cancer
18. Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours
19. Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay
20. Possible mechanisms in the emergence of tamoxifen-resistant breast cancer
21. Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells
22. The adriamycin (III) complex is a potent inhibitor of protein kinase C
23. Inhibitory effect of mitoxantrone on activity of protein kinase C and growth of HL60 cells
24. In vivo effects of doxorubicin on protein kinase C in cultured cells
25. Interaction of P-glycoprotein with protein kinase C in human multidrug resistant carcinoma cells
26. Phorbol ester treatment of U937 cells with altered protein kinase C content and distribution induces cell death rather than differentiation